Volume 199, Issue 2 , Pages 117.e1-117.e6, August 2008
Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells
Objective
The purpose of this study was to screen a panel of targeted adenoviruses as vectors for endometriosis gene therapy.
Study Design
Endometriotic cells were obtained from subjects with ovarian endometriomas. Liver tissues were taken from donors during hepatic transplantation surgery. Human endometriotic cells and liver tissues were transfected by targeted adenoviruses expressing luciferase reporter gene. Luciferase activity that was mediated by each virus was expressed as a percentage of adenovirus serotype 5 (Ad5-CMV-luc) activity. The 2-tailed Studentt test was used to compare the adenovirus data.
Results
In endometriotic cells, the adenovirus-RGD (Ad-RGD-luc), adenovirus under secretory leukocyte protease inhibitor promoter (Ad-SLPI-luc), and adenovirus under heparanase promoter (Ad-heparanase-luc) showed significantly higher activity, compared with the adenovirus serotype 5. In liver tissues, adenovirus-survivin (Ad-survivin-luc) and Ad-heparanase-luc had significantly lower activity, compared with adenovirus serotype 5.
Conclusion
Ad-heparanase-luc showed “endometriosis on, liver off” phenotype and is a promising vector for endometriosis gene therapy.
Key words: adenovirus, endometriosis, gene therapy, targeting strategy
To access this article, please choose from the options below
Cite this article as: Othman ER, Zhu ZB, Curiel DT, et al. Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells. Am J Obstet Gynecol 2008;199:117.e1-117.e6.
Supported by Grants DOD W81XWH-05-1-0035 and NIH R01CA083821 (D.T.C.); G12 RR03032 from the National Center for Research Resources, NIH (A.A.); and a grant from the Egyptian Mission Department (E.R.O.).
PII: S0002-9378(08)00131-2
doi:10.1016/j.ajog.2008.01.059
© 2008 Mosby, Inc. All rights reserved.
Refers to article:
-

Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice
, 12 May 2008
Volume 199, Issue 2 , Pages 117.e1-117.e6, August 2008
